Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and Arrhythmias, Cardiac

angiotensin ii has been researched along with Arrhythmias, Cardiac in 83 studies

Research

Studies (83)

TimeframeStudies, this research(%)All Research%
pre-199017 (20.48)18.7374
1990's14 (16.87)18.2507
2000's27 (32.53)29.6817
2010's20 (24.10)24.3611
2020's5 (6.02)2.80

Authors

AuthorsStudies
Salama, G1
Li, A; Liang, G; Luo, W; Wang, M; Wei, J; Xu, J; Xu, X; Yu, T1
Cha, TJ; Choi, EK; Hajjar, RJ; Jang, SP; Jeong, D; Kook, H; Kwak, TH; Lee, M; Lee, MA; Park, WJ; Raad, N; Song, MH; Yoo, J1
Choy, A; Chung, MK; Khodadadi-Jamayran, A; Lin, X; Narke, D; Offerman, E; Park, DS; Shaheen, D; Shekhar, A; Van Wagoner, DR; Wass, SY; Xiao, J; Yamaguchi, N1
Bers, DM; Bossuyt, J; Hegyi, B; Ko, CY1
Duan, Y; Hai-Kurahara, L; Hiraishi, K; Hu, Y; Ichikawa, J; Inoue, R; Iribe, G; Ma, G; Matsuoka, S; Mori, MX; Nakaya, M; Numata, T; Ohara, H; Takeuchi, A1
Alánová, P; Červenka, L; Falck, JR; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kikerlová, S; Kolář, F; Kompanowska-Jezierska, E; Kopkan, L; Neckář, J; Sadowski, J; Sedláková, L; Vaňourková, Z1
Avery, EG; Balogh, A; Bartolomaeus, H; Dechend, R; Eckardt, KU; Fielitz, J; Forslund, SK; Gollasch, M; Grandoch, M; Haase, N; Hering, L; Höges, S; Homann, S; Kempa, S; Kozhakhmetov, S; Kräker, K; Krannich, A; Kusche-Vihrog, K; Kushugulova, A; Maase, M; Markó, L; Müller, DN; Rump, LC; Stegbauer, J; Tsvetkov, D; Wilck, N; Wundersitz, S; Yakoub, M; Zhumadilov, Z1
Abbott, GW; Anand, M; Christini, DJ; Hu, Z; Kant, R; King, EC; Krogh-Madsen, T1
Huang, K; Ke, Y; Lei, M; Lin, WK; Liu, W; Solaro, RJ; Terrar, DA; Wang, R; Wang, X; Wang, Y; Zhang, Y1
Dai, Z; He, H; Huang, C; Meng, Y; Tang, Y; Wang, X; Xiao, J; Yu, S; Zhao, Q1
Azizian, A; Dantz, C; Dybkova, N; Engels, S; Flebbe, H; Islam, T; Maier, LS; Möllencamp, J; Sag, CM; Shah, AM; Wagner, S1
Leask, A1
Burke, SL; Head, GA; Lukoshkova, EV1
Dursun, N; Guven, C; Kaya, ST; Taskin, E; Tuncer, KA1
Chang, SL; Chen, SA; Chen, YC; Chen, YJ; Chung, FP; Hong, YR; Hsu, WH; Hu, YF; Huang, PH; Kuo, TB; Lin, SF; Lin, YJ; Lo, LW; Su, WC; Sung, YL; Weng, CH; Yeh, HI1
Epstein, JA; Levin, MD; Liu, F; Lu, MM; Patel, VV; Petrenko, NB; Stout, AL; Wang, T; Yuan, LJ1
Curl, CL; Delbridge, LM; Huggins, CE; McLennan, PL; Patel, R; Pedrazzini, T; Pepe, S; Theiss, ML1
De Mello, WC3
Danilo, P; Feinmark, SJ; Lau, DH; Ozgen, N; Rosen, MR; Sherman, W; Shlapakova, IN1
Bers, DM; Blatter, LA; Bodi, I; DeSantiago, J; Domeier, TL; Lorenz, JN; Maillet, M; Mikoshiba, K; Molkentin, JD; Nakayama, H1
Chen, SA; Chen, YC; Chen, YJ; Cheng, CC; Huang, CF; Kao, YH; Lin, YK1
Mace, LC; Murray, KT1
Chen, WP; Chiang, FT; Hwang, JJ; Lai, LP; Lin, JL; Tsai, CT; Tseng, CD; Wang, YC; Wu, CK; Yu, CC1
Akiyama, K; Hata, M; Hirayama, A; Sezai, A; Shiono, M; Unosawa, S; Wakui, S; Yoshitake, I1
Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kolář, F; Kopkan, L; Kramer, HJ; Malý, J; Neckář, J; Netuka, I; Ošťádal, B; Papoušek, F1
Bapat, A; Fishbein, MC; Karagueuzian, HS; Lee, JH; Nguyen, TP; Sovari, AA; Weiss, JN1
Ghigo, A; Hirsch, E; Perino, A; Shah, AM; Zhang, M1
Ecarnot-Laubriet, A; Oudot, A; Rochette, L; Vergely, C1
Díez, J; Fortuño, MA; González, A; López, B; López, N; Querejeta, R; Ravassa, S1
Cheng, J; Guo, H; Lee, JD; Shan, J; Ueda, T; Wang, J1
Nattel, S1
Jin, D; Miyazaki, M; Muramatsu, M; Okamoto, Y; Takai, S1
Bernstein, KE; Campbell, DJ; Capecchi, MR; Dudley, SC; Fuchs, S; Hoit, BD; Kasi, VS; Keshelava, G; Lewis, W; Xiao, HD; Zhao, H1
Chen, KY; Chuang, M; Hunt, D; Kargacin, G; Severson, DL; Shimoni, Y1
Cohen, IS; Rosen, MR1
Rubart, M; Zipes, DP1
Cesario, D; Garg, S; Marelli, C; Narula, J1
Bertuglia, S; Reiter, RJ1
Goette, A; Lendeckel, U1
Dong, F; Sheng, JW; Shi, CX; Wang, YH; Xu, YF1
Fleming, JT; Holl, JE1
Marshall, RJ; Muir, AW; Winslow, E1
Armour, JA; Huang, MH; Wolf, SG1
Kanno, M; Kitabatake, A; Kohya, T; Nakaya, H; Saito, H; Tohse, N; Yokoshiki, H1
Dai, S; Lee, S; McNeill, JH; Todd, ME1
Hirayama, Y; Ibukiyama, C; Iga, K; Ishii, T; Kiyomi, S; Nagai, Y; Ogawa, T; Takata, Y1
Brunner, F; Kukovetz, WR1
Ikram, H1
Ding, YA; Lee, YM; Peng, YY; Yen, MH1
Almeida, AP; Campagnole-Santos, MJ; Khosla, MC; Neves, LA; Santos, RA1
Hunyady, L; Nagy, L1
Gould, RJ; Grossman, W; Kusma, SE; Lynch, JJ; Painter, CA; Stump, GL; Thomas, JM; Wallace, AA1
Marchini, F; Morazzoni, G; Papp, JG; Parratt, JR; Rastegar, MA; Vegh, A1
Almeida, AP; Ferreira, AJ; Santos, RA1
Bishop, SP; Dell'Italia, LJ; Dillon, AR; Hankes, GH; Ideker, R; Powell, P; Rynders, P; Schultz, D; Spinale, FG; Su, X; Walcott, G; Wei, CC1
Ambrosioni, E; Angelini, V; Borghi, C; Gatti, M; Giovagnorio, MT; Grippo, MC; Lepera, G; Maranga, SS; Melandri, F; Naccarella, F; Naccarelli, GV; Nisam, S; Pazzaglia, S; Spinelli, G1
Guo, H; He, H; Jiang, C; Lu, D; Wang, J; Zhou, B1
Andreuzzi, B; Gronda, E; Mangiavacchi, M; Municinò, A1
Browne, AE; Chatterjee, K; Lee, RJ; Parmley, WW; Sievers, RE; Sun, Y; Zhu, B1
Browne, AE; Chair, K; Chatterjee, K; Glantz, SA; Hillman, RT; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ1
Michelis, MF; Murdaugh, HV1
Albrecht, CM; Griffith, WH; Williams, BJ1
Rabkin, SW1
Dietz, R; Fischer, T; Haberbosch, W; Hauck, S; Osterziel, KJ; Süsselbeck, T; Waas, W1
Curtis, MJ1
Bruzzone, F; Canale, C; Caponnetto, S; Licciardello, L; Marchetti, GV; Masperone, MA; Pastorino, L; Terrachini, V1
Frohlich, ED1
Albus, U; Breipohl, G; Knolle, J; Linz, W; Petry, P; Schölkens, BA1
Dzau, VJ1
De Graeff, PA; De Langen, CD; Kingma, JH; Van Gilst, WH; Wesseling, H1
Elliott, K; Horrobin, DF; Jackson, FS; Manku, MS; McNeilly, AS; Nassar, BA; Reid, DS; Tynan, M1
Grodzki, M; Juskowa, J; Krotkiewski, A1
Schröder, R1
Fassolt, A1
Nitschkoff, S; Schönfelder, G1
Cha, HD; Grinnell, EH; Kramár, JL; Meyers, VW1
Messini, M1
Azzarone, G; Leonardis, G; Splendiani, G2

Reviews

16 review(s) available for angiotensin ii and Arrhythmias, Cardiac

ArticleYear
Getting to the heart of the matter: new insights into cardiac fibrosis.
    Circulation research, 2015, Mar-27, Volume: 116, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Atrophy; Cicatrix; Connective Tissue Growth Factor; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Humans; Hypoxia; Models, Cardiovascular; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Platelet-Derived Growth Factor; Pyridones; Rats; Signal Transduction; Transforming Growth Factor beta

2015
NADPH oxidases in heart failure: poachers or gamekeepers?
    Antioxidants & redox signaling, 2013, Mar-20, Volume: 18, Issue:9

    Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Arrhythmias, Cardiac; Enzyme Activation; Fibroblasts; Fibrosis; Heart Failure; Humans; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Leukocytes; Membrane Glycoproteins; Mice; Models, Cardiovascular; Molecular Targeted Therapy; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Neovascularization, Pathologic; Oxidative Stress; Protein Isoforms; Reactive Oxygen Species; Subcellular Fractions

2013
Cardiomyocyte apoptosis in hypertensive cardiomyopathy.
    Cardiovascular research, 2003, Sep-01, Volume: 59, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Apoptosis; Arrhythmias, Cardiac; Humans; Hypertension; MAP Kinase Signaling System; Models, Animal; Myocardial Ischemia; Myocytes, Cardiac; Oxidative Stress; Ventricular Remodeling

2003
Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system.
    Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:2

    Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Cardiac Output, Low; Cell Communication; Fibroblasts; Fibrosis; Humans; Renin-Angiotensin System; Signal Transduction; Sympathetic Nervous System

2004
Chymase-derived angiotensin II and arrhythmias after myocardial infarction.
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2004, Volume: 124, Issue:2

    Topics: Angiotensin II; Arrhythmias, Cardiac; Chymases; Enzyme Activation; Humans; Myocardial Infarction; Serine Endopeptidases

2004
Cardiac memory ... new insights into molecular mechanisms.
    The Journal of physiology, 2006, Jan-15, Volume: 570, Issue:Pt 2

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cyclic AMP Response Element-Binding Protein; Heart; Heart Conduction System; Humans; Ion Channels; Models, Cardiovascular; Myocardial Contraction; Pericardium; Time Factors; Vectorcardiography

2006
Neural modulation of cardiac arrhythmias and sudden cardiac death.
    Heart rhythm, 2006, Volume: 3, Issue:1

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Calcium Signaling; Death, Sudden, Cardiac; Heart; Humans; Nerve Regeneration; Renin-Angiotensin System

2006
Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    The American journal of cardiology, 2006, Mar-15, Volume: 97, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Humans; Renin-Angiotensin System; Treatment Outcome

2006
Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2008, Volume: 10, Issue:2

    Topics: Angiotensin II; Arrhythmias, Cardiac; Gap Junctions; Humans; Ion Channels; Signal Transduction

2008
Opposite effects of angiotensin II and angiotensin (1-7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic?
    Regulatory peptides, 2009, Feb-25, Volume: 153, Issue:1-3

    Topics: Action Potentials; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction

2009
The renin-angiotensin-aldosterone system and cardiac ischaemia.
    Heart (British Cardiac Society), 1996, Volume: 76, Issue:3 Suppl 3

    Topics: Angina Pectoris; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Blood Flow Velocity; Coronary Vessels; Dogs; Humans; Myocardial Infarction; Myocardial Ischemia; Rats; Renin-Angiotensin System; Vasoconstriction

1996
[AT1 angiotensin receptor inhibition as a new therapeutic possibility].
    Orvosi hetilap, 1997, Oct-12, Volume: 138, Issue:41

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Female; Heart Failure; Humans; Hypertension; Losartan; Renin-Angiotensin System

1997
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias(1).
    Cardiovascular research, 2001, Volume: 52, Issue:3

    Topics: Angiotensin II; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computer Simulation; Drug Design; Electrophysiology; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; GTP-Binding Proteins; Heart Conduction System; Humans; Ion Transport; Models, Cardiovascular; Myocardium; Potassium Channels; Stress, Mechanical; Ventricular Remodeling

2001
Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials.
    Current opinion in cardiology, 2002, Volume: 17, Issue:1

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Combined Modality Therapy; Defibrillators, Implantable; Heart Failure; Humans; Prevalence; Randomized Controlled Trials as Topic

2002
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:12

    Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Death, Sudden, Cardiac; Diuretics; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Pacemaker, Artificial; Prognosis; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Spironolactone; Vasodilator Agents

2001
Antihypertensive therapy: newer concepts and agents.
    Cardiology, 1985, Volume: 72, Issue:5-6

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Volume; Calcium Channel Blockers; Diuretics; Hemodynamics; Humans; Hypertension; Hypokalemia; Membrane Potentials; Receptors, Serotonin; Renin; Solubility; Vascular Resistance; Vasodilator Agents

1985

Trials

2 trial(s) available for angiotensin ii and Arrhythmias, Cardiac

ArticleYear
Myocardial protective effect of human atrial natriuretic Peptide in cardiac surgery. -hANP Shot” in clinical safety trial-.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:9

    Topics: Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cardiotonic Agents; Coronary Artery Bypass; Creatine Kinase, MB Form; Cyclic GMP; Dose-Response Relationship, Drug; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart Arrest, Induced; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Postoperative Complications; Renin; Troponin I

2011
[AT1 angiotensin receptor inhibition as a new therapeutic possibility].
    Orvosi hetilap, 1997, Oct-12, Volume: 138, Issue:41

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Female; Heart Failure; Humans; Hypertension; Losartan; Renin-Angiotensin System

1997

Other Studies

66 other study(ies) available for angiotensin ii and Arrhythmias, Cardiac

ArticleYear
Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy.
    Journal of the American Heart Association, 2022, 08-02, Volume: 11, Issue:15

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arrhythmias, Cardiac; Cardiomegaly; Humans; Receptor, Angiotensin, Type 1

2022
Ginsenoside Rg5 alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the JNK/AP-1 pathway.
    International immunopharmacology, 2023, Volume: 120

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Heart Failure; Hypertension; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Transcription Factor AP-1

2023
The matricellular protein CCN5 prevents adverse atrial structural and electrical remodelling.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:20

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Remodeling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line; Cell Transdifferentiation; Dependovirus; Electrophysiological Phenomena; Fibrosis; Heart Atria; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Myofibroblasts

2020
Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling.
    Circulation, 2021, 02-23, Volume: 143, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Arrhythmias, Cardiac; Disease Models, Animal; DNA-Binding Proteins; Down-Regulation; Female; Heart Atria; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neuregulin-1; Receptor, Transforming Growth Factor-beta Type I; Transcription Factors; Ventricular Remodeling; Young Adult

2021
Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycaemia: reduced repolarization reserve, neurohormonal stimulation, and heart failure exacerbate susceptibility.
    Cardiovascular research, 2021, 12-17, Volume: 117, Issue:14

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Glucose; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetes Mellitus; Disease Models, Animal; Heart Conduction System; Heart Failure; Heart Rate; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Potassium Channels; Rabbits; Ryanodine Receptor Calcium Release Channel

2021
Uncovering the arrhythmogenic potential of TRPM4 activation in atrial-derived HL-1 cells using novel recording and numerical approaches.
    Cardiovascular research, 2017, Aug-01, Volume: 113, Issue:10

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Calcium Signaling; Computer Simulation; Heart Atria; Heart Rate; HEK293 Cells; Humans; Kinetics; Mice; Models, Cardiovascular; Myocytes, Cardiac; Numerical Analysis, Computer-Assisted; Patch-Clamp Techniques; Refractory Period, Electrophysiological; TRPM Cation Channels

2017
Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.
    Journal of hypertension, 2018, Volume: 36, Issue:6

    Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acids; Arrhythmias, Cardiac; Blood Pressure; Hypertension; Rats; Rats, Sprague-Dawley; Rats, Transgenic

2018
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
    Circulation, 2019, 03-12, Volume: 139, Issue:11

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial Pressure; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Hypertension; Male; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Propionates; T-Lymphocytes, Regulatory; Th17 Cells

2019
Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death.
    Circulation. Cardiovascular genetics, 2014, Volume: 7, Issue:1

    Topics: Anemia; Angiotensin II; Angiotensinogen; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Diabetes Mellitus; Dyslipidemias; Gene Regulatory Networks; Genotype; Heterozygote; Hyperkalemia; Ischemia; Long QT Syndrome; Mice; Mice, Knockout; Potassium Channels, Voltage-Gated

2014
Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; p21-Activated Kinases; Peptides; Rats

2014
Renal sympathetic denervation suppresses ventricular substrate remodelling in a canine high-rate pacing model.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:3

    Topics: Aldosterone; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Catheter Ablation; Disease Models, Animal; Disease Progression; Dogs; Female; Fibrosis; Heart Failure; Heart Ventricles; Kidney; Male; Natriuretic Peptide, Brain; Sympathectomy; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling

2014
NADPH oxidase 2 mediates angiotensin II-dependent cellular arrhythmias via PKA and CaMKII.
    Journal of molecular and cellular cardiology, 2014, Volume: 75

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Calcium Channels, L-Type; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP-Dependent Protein Kinases; Cytosol; Ion Channel Gating; Membrane Glycoproteins; Mice; Mitochondria; NADPH Oxidase 2; NADPH Oxidases; Rats, Wistar; Reactive Oxygen Species; Sodium Channels

2014
Characteristics of renal sympathetic nerve single units in rabbits with angiotensin-induced hypertension.
    Experimental physiology, 2016, Volume: 101, Issue:1

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Baroreflex; Dose-Response Relationship, Drug; Electrocardiography; Heart; Hemodynamics; Hypertension; Kidney; Male; Rabbits; Sympathetic Nervous System; Vasoconstrictor Agents

2016
Inhibition of Angiotensin-II Production Increases Susceptibility to Acute Ischemia/Reperfusion Arrhythmia.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Nov-27, Volume: 22

    Topics: Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Captopril; Creatine Kinase, MB Form; Fumarates; Heart; Heart Rate; Male; Myocardial Reperfusion Injury; Oxidative Stress; Rats

2016
Pleiotropic Effects of Myocardial MMP-9 Inhibition to Prevent Ventricular Arrhythmia.
    Scientific reports, 2016, 12-14, Volume: 6

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Calcium; Calcium Signaling; Cyclic AMP-Dependent Protein Kinases; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Myocardium; Ryanodine Receptor Calcium Release Channel

2016
Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin.
    Journal of molecular and cellular cardiology, 2008, Volume: 45, Issue:6

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomegaly; Connexins; Enzyme Inhibitors; Fibrosis; Gap Junction alpha-5 Protein; Histone Deacetylase Inhibitors; Histone Deacetylases; Homeodomain Proteins; Hydroxamic Acids; Mice; Mice, Transgenic; Time Factors

2008
Dietary fish oil is antihypertrophic but does not enhance postischemic myocardial function in female mice.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:4

    Topics: Angiotensin II; Angiotensinogen; Animals; Arrhythmias, Cardiac; Dietary Fats, Unsaturated; Disease Models, Animal; Estrogens; Female; Fish Oils; Genetic Predisposition to Disease; Hypertrophy; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Ovariectomy; Reperfusion Injury

2009
Cell swelling, impulse conduction, and cardiac arrhythmias in the failing heart. Opposite effects of angiotensin II and angiotensin (1-7) on cell volume regulation.
    Molecular and cellular biochemistry, 2009, Volume: 330, Issue:1-2

    Topics: Angiotensin I; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Cell Size; Cells, Cultured; Cricetinae; Electrophysiology; Heart Conduction System; Heart Failure; Heart Ventricles; Hypotonic Solutions; Male; Membrane Potentials; Myocytes, Cardiac; Peptide Fragments; Pulse

2009
Determinants of CREB degradation and KChIP2 gene transcription in cardiac memory.
    Heart rhythm, 2010, Volume: 7, Issue:7

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Blotting, Western; Cardiac Pacing, Artificial; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Dogs; Heart Conduction System; Ion Channels; Kv Channel-Interacting Proteins; Lipid Peroxidation; Male; Models, Animal; Models, Cardiovascular; Myocardium; Myocytes, Cardiac; Oxidative Stress; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Ubiquitin; Ubiquitination; Ventricular Function, Left; Ventricular Remodeling

2010
The IP3 receptor regulates cardiac hypertrophy in response to select stimuli.
    Circulation research, 2010, Sep-03, Volume: 107, Issue:5

    Topics: Age Factors; Angiotensin II; Animals; Arrhythmias, Cardiac; Calcineurin; Calcium Signaling; Cardiomegaly; Disease Models, Animal; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Isoproterenol; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; Phenotype; Physical Exertion

2010
Heat-stress responses modulate beta-adrenergic agonist and angiotensin II effects on the arrhythmogenesis of pulmonary vein cardiomyocytes.
    Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:2

    Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Angiotensin II; Animals; Arrhythmias, Cardiac; Cells, Cultured; Heat-Shock Response; Myocytes, Cardiac; Pulmonary Veins; Rabbits

2011
Preventing atrial fibrillation: more evidence to turn up the heat.
    Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:2

    Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Angiotensin II; Animals; Arrhythmias, Cardiac; Cells, Cultured; Evidence-Based Medicine; Heat-Shock Response; Hyperthermia, Induced; Myocytes, Cardiac; Pulmonary Veins; Rabbits

2011
Angiotensin II induces complex fractionated electrogram in a cultured atrial myocyte monolayer mediated by calcium and sodium-calcium exchanger.
    Cell calcium, 2011, Volume: 49, Issue:1

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Calcium Signaling; Cell Membrane; Cells, Cultured; Connexin 43; Electrophysiological Phenomena; Extracellular Space; Heart Atria; Immunohistochemistry; Ion Channel Gating; Mice; Microelectrodes; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Sodium-Calcium Exchanger

2011
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
    Clinical science (London, England : 1979), 2012, Volume: 122, Issue:11

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Benzoates; Blood Pressure; Cardiotonic Agents; Eicosanoids; Epoxide Hydrolases; Female; Hypertension; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Urea

2012
Enhanced sensitivity of aged fibrotic hearts to angiotensin II- and hypokalemia-induced early afterdepolarization-mediated ventricular arrhythmias.
    American journal of physiology. Heart and circulatory physiology, 2012, Jun-01, Volume: 302, Issue:11

    Topics: Aging; Angiotensin II; Animals; Arrhythmias, Cardiac; Disease Models, Animal; Fibrosis; Heart; Hypokalemia; Male; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; Patch-Clamp Techniques; Rats; Rats, Inbred F344; Reactive Oxygen Species; Ventricular Fibrillation

2012
Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion.
    European journal of pharmacology, 2003, Feb-21, Volume: 462, Issue:1-3

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Coronary Circulation; Enzyme Activation; Heart; In Vitro Techniques; L-Lactate Dehydrogenase; Losartan; Male; Membrane Glycoproteins; Membrane Transport Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NADPH Dehydrogenase; NADPH Oxidase 2; NADPH Oxidases; Perfusion; Phosphoproteins; Rats; Rats, Wistar; RNA, Messenger; Vasoconstrictor Agents; Ventricular Function, Left

2003
Relationship between hypertensive left ventricular hypertrophy, neurohormonal factors and ventricular arrhythmias in very old patients.
    Acta cardiologica, 2004, Volume: 59, Issue:1

    Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Biomarkers; Coronary Angiography; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin; Male; Neurotransmitter Agents; Renin

2004
Defining "culprit mechanisms" in arrhythmogenic cardiac remodeling.
    Circulation research, 2004, Jun-11, Volume: 94, Issue:11

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Dogs; Fibrosis; Heart Atria; Heart Failure; Humans; Mice; Mice, Transgenic; Models, Animal; Myocardium; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling

2004
Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.
    The American journal of pathology, 2004, Volume: 165, Issue:3

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Bradykinin; Death, Sudden; Disease Models, Animal; Female; Gene Targeting; Heart Block; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myosin Heavy Chains; Peptidyl-Dipeptidase A; Promoter Regions, Genetic; Recombination, Genetic; Tissue Distribution

2004
Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat.
    The Journal of physiology, 2005, Aug-15, Volume: 567, Issue:Pt 1

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cells, Cultured; Diabetes Mellitus, Experimental; Female; Heart Ventricles; Hyperglycemia; Male; Membrane Potentials; Myocytes, Cardiac; Oxidative Stress; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Sex Characteristics; Superoxides

2005
Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters.
    Journal of pineal research, 2007, Volume: 42, Issue:1

    Topics: Angiotensin II; Animals; Antioxidants; Arrhythmias, Cardiac; Arterioles; Capillary Permeability; Cardiomyopathy, Dilated; Cell Adhesion; Cricetinae; Endothelium, Vascular; Leukocytes; Lipid Peroxidation; Male; Melatonin; Mesocricetus; Microcirculation; Nitrates; Nitrites; Norepinephrine; omega-N-Methylarginine; Reperfusion Injury

2007
Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor.
    British journal of pharmacology, 2008, Volume: 154, Issue:2

    Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arrhythmias, Cardiac; Cell Line; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Heart Ventricles; Humans; Indoles; Ion Channel Gating; Losartan; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium; Protein Kinase C; Protein Kinase Inhibitors; Receptor, Angiotensin, Type 1; Signal Transduction; Staurosporine; Time Factors; Transfection

2008
Centrally mediated enhancement of ouabain cardiotoxicity by angiotensin II in dogs.
    European journal of pharmacology, 1982, Dec-03, Volume: 85, Issue:3-4

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Pressure; Brain; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Heart; Infusions, Parenteral; Injections, Intra-Arterial; Male; Myocardium; Ouabain; Spinal Cord; Sympathetic Nervous System

1982
Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat.
    British journal of pharmacology, 1981, Volume: 73, Issue:4

    Topics: Androstanols; Angiotensin II; Animals; Arrhythmias, Cardiac; Atropine; Catecholamines; Coronary Vessels; Disease Models, Animal; Disopyramide; Epinephrine; Isoproterenol; Norepinephrine; Phenylephrine; Practolol; Rats; Ventricular Fibrillation

1981
Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurones.
    Cardiovascular research, 1994, Volume: 28, Issue:5

    Topics: Adenosine; Adenosine Triphosphate; Angiotensin II; Animals; Arrhythmias, Cardiac; Autonomic Agents; Bethanechol; Bethanechol Compounds; Bradykinin; Dogs; Female; Glutamates; Heart; Isoproterenol; Male; Myocardial Contraction; Neurons; Nicotine; Peptides; Purines; Substance P; Vasoactive Intestinal Peptide

1994
Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
    Circulation research, 1995, Volume: 76, Issue:5

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Body Weight; Captopril; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Organ Size; Rats; Rats, Inbred SHR; Tetrazoles

1995
Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats.
    Canadian journal of physiology and pharmacology, 1994, Volume: 72, Issue:7

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Drinking; Eating; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin; Male; Pulse; Rats; Rats, Wistar; Triglycerides

1994
The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion.
    Cardiovascular research, 1996, Volume: 32, Issue:2

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Female; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium

1996
Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
    Circulation, 1996, Oct-01, Volume: 94, Issue:7

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Bradykinin Receptor Antagonists; Endothelin Receptor Antagonists; Endothelins; Female; Heart; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley

1996
Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.
    American journal of hypertension, 1997, Volume: 10, Issue:8

    Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Heart Rate; Hemodynamics; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Inbred SHR

1997
Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1997, Volume: 30, Issue:6

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Reperfusion; Norepinephrine; Rats; Rats, Wistar; Renin-Angiotensin System; Vasoconstrictor Agents

1997
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
    Journal of the American College of Cardiology, 1999, Volume: 34, Issue:3

    Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Heart Ventricles; Humans; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Tetrazoles; Time Factors

1999
The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    British journal of pharmacology, 2000, Volume: 129, Issue:4

    Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Bradykinin; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Female; Kidney; Lung; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neprilysin; Peptidyl-Dipeptidase A; Phenylalanine

2000
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:3 Pt 2

    Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar

2001
Downregulation of ANG II receptor is associated with compensated pressure-overload hypertrophy in the young dog.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:2

    Topics: Adaptation, Physiological; Age Factors; Angiotensin II; Animals; Aorta; Arrhythmias, Cardiac; Blood Pressure; Cardiac Volume; Cardiomegaly; Disease Models, Animal; Dogs; Down-Regulation; Electrophysiology; Gene Expression; Muscle Fibers, Skeletal; Myocardium; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Ventricular Function, Left

2002
[Study on the relation between hypertensive left ventricular hypertrophy in very old people with neurohormonal factors and ventricular arrhythmias].
    Zhonghua nei ke za zhi, 2000, Volume: 39, Issue:12

    Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Myocardial Ischemia; Renin

2000
Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2001, Volume: 2, Issue:2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Endothelial Growth Factors; Endothelium, Vascular; Female; Losartan; Lymphokines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilation

2001
The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2002, Volume: 3, Issue:1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Electrocardiography; Endothelial Growth Factors; Endothelium, Vascular; Female; Hemodynamics; Losartan; Lymphokines; Muscle, Smooth, Vascular; Myocardial Infarction; Nicotine; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Renin; Renin-Angiotensin System; Reperfusion Injury; Tobacco Smoke Pollution; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Fibrillation

2002
Selective hypoaldosteronism. An editorial revisited after 15 years.
    The American journal of medicine, 1975, Volume: 59, Issue:1

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Heart; Humans; Metabolism, Inborn Errors; Muscles; Potassium; Renin; Sodium

1975
The protective effect of phentolamine against cardiac arrhythmias in the rat.
    European journal of pharmacology, 1978, May-01, Volume: 49, Issue:1

    Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclic AMP; Male; Methoxamine; Myocardium; Norepinephrine; Phentolamine; Propranolol; Rats; Tolazoline; Yohimbine

1978
Angiotensin in the brain suppresses epinephrine-induced cardiac arrhythmias through CNS opioid mechanisms.
    Life sciences, 1991, Volume: 49, Issue:16

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Pressure; Brain; Captopril; Epinephrine; Heart Rate; Male; Narcotic Antagonists; Rats; Rats, Inbred Strains; Receptors, Opioid; Saralasin

1991
Modulation of coronary circulation and the cardiac matrix by the renin-angiotensin system.
    European heart journal, 1991, Volume: 12 Suppl F

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Coronary Circulation; Heart Failure; Humans; Renin-Angiotensin System; Vasoconstriction

1991
The pathophysiological basis of arrhythmogenesis in myocardial ischemia and reperfusion: possible target for intervention.
    Bratislavske lekarske listy, 1991, Volume: 92, Issue:2

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Catecholamines; Cyclic AMP; Free Radicals; Humans; Myocardial Reperfusion Injury; Potassium; Rabbits

1991
Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations.
    Cardiology, 1990, Volume: 77 Suppl 5

    Topics: Administration, Oral; Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Renin; Vasodilator Agents

1990
Atrial natriuretic factor protects the isolated working ischaemic rat heart against the action of angiotensin II.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1988, Volume: 6, Issue:4

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Coronary Circulation; Coronary Disease; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Ventricular Fibrillation

1988
Cardiac renin-angiotensin system. Molecular and functional aspects.
    The American journal of medicine, 1988, Mar-11, Volume: 84, Issue:3A

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Heart; Humans; Myocardial Contraction; Myocardium; Rats; Renin-Angiotensin System; Reperfusion Injury

1988
Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heart.
    Archives internationales de pharmacodynamie et de therapie, 1986, Volume: 280, Issue:2

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Captopril; Coronary Circulation; Coronary Disease; Electrocardiography; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Norepinephrine; Rats; Rats, Inbred Strains

1986
Letter: Prolactin and myocardial infarction.
    Lancet (London, England), 1973, Dec-01, Volume: 2, Issue:7840

    Topics: Angiotensin II; Arrhythmias, Cardiac; Female; Heart; Humans; Male; Myocardial Infarction; Norepinephrine; Prolactin; Radioimmunoassay

1973
Effect of single injections and intravenous infusions of noradrenalin and hypertension on the lelectrocardiographic pattern of dog in shock.
    Polish medical journal, 1967, Volume: 6, Issue:2

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Pressure Determination; Dogs; Electrocardiography; Female; Heart Rate; Injections, Intravenous; Male; Norepinephrine; Shock, Hemorrhagic

1967
[Importance of regional circulation for treatment of cardiogenic shock].
    Arzneimittel-Forschung, 1969, Volume: 19, Issue:5

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Arteries; Blood Pressure; Cardiac Output; Dogs; Epinephrine; Heart Rate; Hemodynamics; Humans; Lactates; Metaproterenol; Myocardial Infarction; Oxygen Consumption; Pyruvates; Regional Blood Flow; Shock; Vascular Resistance; Veins

1969
[Compatibility of hypertension and halothane].
    Der Anaesthesist, 1969, Volume: 18, Issue:6

    Topics: Anesthesia, Endotracheal; Angiotensin II; Arrhythmias, Cardiac; Drug Synergism; Electrocardiography; Halothane; Humans; Propranolol

1969
[Comparative studies on cardiac stimulus formation disturbances in normotonic and hypertonic rabbits during administration of synthetic angiotensin II].
    Das Deutsche Gesundheitswesen, 1970, Jan-09, Volume: 25, Issue:1

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Electrocardiography; Female; Hypertension, Renal; Male; Rabbits

1970
Postinfarction myocardial hypersensitivity to naturally occurring humoral agents in dogs.
    The American journal of the medical sciences, 1970, Volume: 260, Issue:2

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Drug Hypersensitivity; Epinephrine; Female; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Male; Myocardial Infarction; Norepinephrine; Vasopressins

1970
[Therapeutic action of digitalis and substances with analogous action. Lecture 3].
    La Clinica terapeutica, 1971, Feb-15, Volume: 56, Issue:3

    Topics: Angiotensin II; Arrhythmias, Cardiac; Blood Circulation; Blood Pressure; Cardiac Glycosides; Coronary Vessels; Digitalis Glycosides; Diuresis; Heart Conduction System; Heart Diseases; Heart Rate; Hemodynamics; Humans; Kidney; Renin

1971
[Arrhythmias caused by hypertensive and beta-blocking drugs. Personal studies].
    Minerva anestesiologica, 1968, Volume: 34, Issue:3

    Topics: Adrenergic beta-Antagonists; Anesthesia, General; Angiotensin II; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Halothane; Heart Conduction System; Mephentermine; Sympatholytics

1968
[Butydrine in the treatment of arrhythmia caused by hypertensive drugs in the course of fluothane anesthesia].
    Minerva anestesiologica, 1969, Volume: 35, Issue:10

    Topics: Adrenergic beta-Antagonists; Anesthesia, Inhalation; Angiotensin II; Animals; Arrhythmias, Cardiac; Dogs; Epinephrine; Halothane; Mephentermine; Norepinephrine; Propranolol; Sympatholytics

1969